| | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| License data |
|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.051.024 |
| Chemical and physical data | |
| Formula | C15H13N3O2S |
| Molar mass | 299.35 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Fenbendazole is a broad-spectrum benzimidazole anthelmintic used against gastrointestinal parasites including: roundworms, hookworms, whipworms, the tapeworm genus Taenia (but not effective against Dipylidium caninum , a common dog tapeworm), pinworms, Aelurostrongylus spp., paragonimiasis, strongyles, and strongyloides that can be administered to sheep, cattle, horses, fish, dogs, cats, rabbits, most reptiles, freshwater shrimp tanks as planaria and hydra treatments, and seals.
It has not been tested or approved for use in humans by the FDA or EMA. [1] Related benzimidazole drugs such as mebendazole and albendazole are used in humans.
Some laboratory research has shown promising results for fenbendazole and mebendazole as anticancer drugs. Exaggerated information has circulated on social media promoting fenbendazole as a miracle cancer cure. However, the possible use of fenbendazole against cancer is still at the stage of very early laboratory research, and should not be attempted without a doctor's approval and supervision. Misuse of fenbendazole can cause liver damage.
Fenbendazole works by binding to tubulin, a protein that is part of the microtubules in the cells of parasites. This binding disrupts the microtubules' formation [2] and function, leading to the parasites' inability to absorb nutrients, resulting in their eventual death. This mode of action makes fenbendazole effective against both adult and larval stages of many parasitic worms. [3] [4]
Fenbendazole is commonly used to treat intestinal parasites, including roundworms, hookworms, whipworms, and certain tapeworms. It is often administered as part of a broader deworming protocol. [5]
In equine medicine, fenbendazole is used to control strongyles, pinworms, and ascarids. It is available in paste form for easy administration. [6]
Fenbendazole is effective against lungworms, stomach worms, and intestinal worms in ruminants. It is administered through feed, drenching, or bolus form. [7]
Drug interactions may occur if salicylanilides such as dibromsalan and niclosamide are co-administered. Abortions in cattle and death in sheep have been reported after using these medications together. [8] Abortions in domestic ruminants have been associated with concurrent use of antitrematode therapeutic agents. [9]
The appropriate dosage of the medication fenbendazole depends on the specific animal species being treated, as well as the particular formulation or preparation of the fenbendazole product being used. To ensure the correct dosage, considering the animal species being treated with its weight, using a dosage calculator like the Fenbendazole Paraclear Defense Dosage Calculator would be recommended. [10] [11]
Fenbendazole is poorly absorbed from the gastrointestinal tract in most species. The LD50 in laboratory animals exceeds 10 g/kg when administered orally. [8]
Fenbendazole is metabolized in the liver to oxfendazole, which is anthelmintic, too; oxfendazole partially gets reduced back to fenbendazole in the liver and rumen. [12] [13] Also, fenbendazole itself is an active metabolite of another anthelmintic drug, febantel. [14]
Fenbendazole is generally safe when used as directed, but following veterinary guidelines and dosage instructions to avoid potential side effects is important. Some animals may experience mild gastrointestinal upset. It is not recommended for use in pregnant animals without veterinary advice. [15]
Two case reports describe dangerous liver injury in human patients taking fenbendazole off-label. When they stopped taking the drug, the liver injury resolved. [16] [17]
Fenbendazole has been proposed for repurposing as an anticancer drug due to its ability to disrupt energy metabolism in cancer cells and induce cell death through multiple mechanisms. Early results with fenbendazole and the related drug mebendazole are somewhat promising, from in vitro studies, animal studies and a few case reports from people who took it off-label. Fenbendazole's poor bioavailability when administered orally, though, remains a challenge for its use as a cancer treatment. Some patients taking fenbendazole off-label without a doctor's supervision suffered potentially dangerous liver dysfunction, although this resolved after stopping taking the drug. [18] [19] [20]
Exaggerated reports have circulated on social media that fenbendazole is a "miracle cure" for cancers, often with the use of florid testimonials. This information, however, is often less conclusive than it appears, such as reports from patients who were taking fenbendazole alongside conventional drugs, radiation and/or surgery, making it impossible to tell what caused their recovery. [20]
{{cite journal}}: CS1 maint: overridden setting (link)